Antiretroviral therapy coverage in Low income
Low income: Antiretroviral therapy coverage was 81.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Low income, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Low income is 81.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 3.8% on the previous year and up 102.9% over ten years.
Over the whole period, antiretroviral therapy coverage in Low income peaked at 81.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Low income 14th out of 23 groups with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Low income, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.2% | — |
| 2002 | 0.2% | +10.1% |
| 2003 | 0.4% | +112.6% |
| 2004 | 1.8% | +344.3% |
| 2005 | 3.6% | +97.3% |
| 2006 | 5.5% | +54.7% |
| 2007 | 8.7% | +58.5% |
| 2008 | 12.7% | +46.0% |
| 2009 | 15.7% | +23.5% |
| 2010 | 19.3% | +22.8% |
| 2011 | 22.8% | +18.4% |
| 2012 | 27.1% | +18.6% |
| 2013 | 33.2% | +22.6% |
| 2014 | 39.9% | +20.2% |
| 2015 | 44.9% | +12.5% |
| 2016 | 51.4% | +14.5% |
| 2017 | 58.0% | +12.8% |
| 2018 | 60.7% | +4.7% |
| 2019 | 64.0% | +5.5% |
| 2020 | 67.0% | +4.6% |
| 2021 | 70.9% | +5.7% |
| 2022 | 74.4% | +5.0% |
| 2023 | 78.0% | +4.9% |
| 2024 | 81.0% | +3.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.9% | 0.0% | 15.7% | 10 |
| 2010s | 42.1% | 19.3% | 64.0% | 10 |
| 2020s | 74.2% | 67.0% | 81.0% | 5 |
Countries ranked near Low income
More health data for Low income
- Population ages 40-44, female, per capita 0.0225 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.027 units per person (2025)
- Population ages 40-44, female, annual growth rate 3.49 % change on previous year (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 3.59 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0218 units per person (2025)
- Population ages 35-39, male, annual growth rate 3.86 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 3.55 % change on previous year (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Low income?
- Antiretroviral therapy coverage in Low income was 81.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Low income?
- The highest recorded value was 81.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Low income?
- The lowest recorded value was 0.0% in 2000.
- How does Low income rank for antiretroviral therapy coverage?
- Low income ranks 14th out of 23 groups with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Low income?
- Over the last ten years it is up 102.9%. The long-run trend across the full record is volatile.
- Where does this Low income data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.